| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.266.597.286 $ | +739.222.805 $ | +66,3 % | 7 | 930.836.657 $ | -3.391.121 $ | -17,7 % | 7 | 934.227.778 $ | +347.317.086 $ | +49,3 % | 7 | ||||
| ISHARES TR | → 0 | 483.119.683 $ | +483.119.683 $ | 1 | |||||||||||
| QXO, Inc. | QXO | → 0 | Sehr schwach | 269.130.419 $ | -139.381.916 $ | -34,1 % | 1 | 408.512.335 $ | -16.442.087 $ | -3,9 % | 1 | 424.954.422 $ | -30.678.355 $ | -6,7 % | 1 |
| iSHARES TRUST | → 0 | 398.040.720 $ | +6.791.400 $ | +1,7 % | 1 | 391.249.320 $ | +265.012.170 $ | +209,9 % | 1 | ||||||
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 366.367.891 $ | +366.367.891 $ | 1 | ||||||||||
| RXO, Inc. | RXO | → 0 | Neutral | 147.276.295 $ | +28.602.002 $ | +24,1 % | 1 | 118.674.293 $ | +6.910.309 $ | +6,2 % | 1 | 111.763.984 $ | +111.763.984 $ | 1 | |
| Solid Biosciences Inc. | SLDB | → 0 | Neutral | 5.421.456 $ | -509.463 $ | -8,6 % | 1 | 5.930.919 $ | +1.249.627 $ | +26,7 % | 1 | ||||
| AleAnna, Inc. | ANNA | → 0 | Stark | 626.674 $ | +478.346 $ | +322,5 % | 1 | 148.328 $ | -79.249 $ | -34,8 % | 1 | 227.577 $ | -87.135 $ | -27,7 % | 1 |
| MoneyHero Ltd | MNY | → 0 | 76.075 $ | +37.769 $ | +98,6 % | 1 | 38.306 $ | -61.666 $ | -61,7 % | 1 | 99.972 $ | +58.086 $ | +138,7 % | 1 | |
| Calidi Biotherapeutics, Inc. | CLDI | → 0 | Schwach | 249 $ | -970 $ | -79,6 % | 1 | 1.219 $ | -365 $ | -23,0 % | 1 | 1.584 $ | -1.291 $ | -44,9 % | 1 |
| 1.266.597.286 $ | +739.222.805 $ | +66,3 % | 7 | 930.836.657 $ | -3.391.121 $ | -17,7 % | 7 | 934.227.778 $ | +347.317.086 $ | +49,3 % | 7 | ||||